Category: biotech

.AstraZeneca has used artificial intelligence to design a distinct biomarker for its Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), planning to vary the antibody-drug conjugate (ADC) from

.AN2 Therapies is reassessing its own organization in response to lackluster midphase information, swearing to lay off half its staff members and cease a phase

.ALX Oncology’s stage 2 gastric cancer reaction rate has deteriorated. After seeing its CD47 blocker easily beat command over the first one-half of the test,

.After much more than twenty years of work on neurodegenerative ailments, Swiss biotech a/c Immune system claims it could possibly possess a game changer on